| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ubiquitin-Protein Ligases | 46 | 2021 | 1889 | 4.820 |
Why?
|
| Ubiquitination | 21 | 2021 | 1008 | 3.120 |
Why?
|
| Ubiquitin | 20 | 2021 | 838 | 3.060 |
Why?
|
| Autophagy | 17 | 2021 | 1337 | 2.660 |
Why?
|
| Cullin Proteins | 13 | 2021 | 178 | 2.550 |
Why?
|
| Mitochondria | 16 | 2021 | 3600 | 2.360 |
Why?
|
| Ribosomes | 6 | 2020 | 501 | 2.260 |
Why?
|
| Mitochondrial Membranes | 5 | 2020 | 172 | 1.980 |
Why?
|
| Ubiquitins | 19 | 2017 | 370 | 1.760 |
Why?
|
| Cell Cycle Proteins | 35 | 2019 | 3446 | 1.760 |
Why?
|
| Mitochondrial Proteins | 9 | 2020 | 979 | 1.750 |
Why?
|
| Proteomics | 26 | 2021 | 3817 | 1.670 |
Why?
|
| Protein Kinases | 11 | 2020 | 1612 | 1.640 |
Why?
|
| Cyclin-Dependent Kinases | 16 | 2016 | 656 | 1.390 |
Why?
|
| F-Box Proteins | 7 | 2021 | 202 | 1.330 |
Why?
|
| Proteome | 13 | 2020 | 1855 | 1.280 |
Why?
|
| HeLa Cells | 22 | 2020 | 3105 | 1.240 |
Why?
|
| Thiolester Hydrolases | 3 | 2020 | 85 | 1.220 |
Why?
|
| rab GTP-Binding Proteins | 3 | 2018 | 251 | 1.210 |
Why?
|
| Guanine Nucleotide Exchange Factors | 7 | 2018 | 568 | 1.090 |
Why?
|
| Protein Biosynthesis | 5 | 2020 | 2105 | 1.020 |
Why?
|
| Ligases | 13 | 2003 | 332 | 0.990 |
Why?
|
| Protein Interaction Mapping | 7 | 2017 | 617 | 0.950 |
Why?
|
| Lysosomes | 6 | 2021 | 920 | 0.940 |
Why?
|
| CDC2-CDC28 Kinases | 7 | 2003 | 110 | 0.920 |
Why?
|
| Peptide Synthases | 12 | 2002 | 80 | 0.920 |
Why?
|
| Phosphorylation | 27 | 2020 | 8313 | 0.850 |
Why?
|
| Neurogenesis | 2 | 2020 | 856 | 0.820 |
Why?
|
| Nuclear Receptor Coactivators | 4 | 2019 | 61 | 0.810 |
Why?
|
| Neural Stem Cells | 2 | 2020 | 884 | 0.770 |
Why?
|
| Proteasome Endopeptidase Complex | 7 | 2019 | 1313 | 0.770 |
Why?
|
| Microtubule-Associated Proteins | 5 | 2019 | 1077 | 0.760 |
Why?
|
| SKP Cullin F-Box Protein Ligases | 13 | 2013 | 174 | 0.730 |
Why?
|
| Cyclins | 13 | 1999 | 593 | 0.710 |
Why?
|
| Adaptor Proteins, Signal Transducing | 8 | 2017 | 2895 | 0.710 |
Why?
|
| Cyclin E | 7 | 2003 | 155 | 0.710 |
Why?
|
| Multiprotein Complexes | 8 | 2019 | 1120 | 0.700 |
Why?
|
| Ubiquitin-Protein Ligase Complexes | 7 | 2007 | 169 | 0.680 |
Why?
|
| Endoplasmic Reticulum | 4 | 2020 | 1132 | 0.670 |
Why?
|
| Protein Processing, Post-Translational | 8 | 2021 | 1974 | 0.660 |
Why?
|
| HEK293 Cells | 20 | 2020 | 4264 | 0.650 |
Why?
|
| Saccharomyces cerevisiae Proteins | 18 | 2020 | 1854 | 0.640 |
Why?
|
| Erythropoiesis | 3 | 2019 | 682 | 0.640 |
Why?
|
| Class III Phosphatidylinositol 3-Kinases | 1 | 2017 | 17 | 0.610 |
Why?
|
| Protein Binding | 30 | 2021 | 9335 | 0.580 |
Why?
|
| Signal Transduction | 16 | 2020 | 23376 | 0.580 |
Why?
|
| Tumor Suppressor Proteins | 9 | 2018 | 2802 | 0.560 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 8 | 2021 | 198 | 0.540 |
Why?
|
| Polyubiquitin | 3 | 2017 | 68 | 0.540 |
Why?
|
| Proto-Oncogene Proteins | 9 | 2018 | 4490 | 0.540 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2017 | 140 | 0.530 |
Why?
|
| Databases, Protein | 2 | 2017 | 388 | 0.520 |
Why?
|
| Ferritins | 2 | 2015 | 597 | 0.510 |
Why?
|
| Membrane Potential, Mitochondrial | 2 | 2014 | 296 | 0.500 |
Why?
|
| Cell Line | 25 | 2022 | 15620 | 0.500 |
Why?
|
| RNA Precursors | 1 | 2016 | 212 | 0.490 |
Why?
|
| Protein Subunits | 5 | 2019 | 943 | 0.490 |
Why?
|
| Neurons | 7 | 2022 | 9426 | 0.480 |
Why?
|
| Unfolded Protein Response | 1 | 2016 | 233 | 0.460 |
Why?
|
| G1 Phase | 7 | 2003 | 403 | 0.460 |
Why?
|
| Carrier Proteins | 11 | 2017 | 4938 | 0.450 |
Why?
|
| Stress, Physiological | 2 | 2021 | 1398 | 0.450 |
Why?
|
| Qc-SNARE Proteins | 1 | 2013 | 20 | 0.440 |
Why?
|
| Phosphoproteins | 3 | 2017 | 2440 | 0.440 |
Why?
|
| Membrane Proteins | 8 | 2020 | 7850 | 0.440 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2016 | 415 | 0.440 |
Why?
|
| Cell Cycle | 17 | 2019 | 2934 | 0.440 |
Why?
|
| Fanconi Anemia Complementation Group Proteins | 1 | 2013 | 97 | 0.430 |
Why?
|
| HCT116 Cells | 5 | 2020 | 402 | 0.430 |
Why?
|
| Adenosine Triphosphatases | 3 | 2019 | 832 | 0.430 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 1 | 2013 | 151 | 0.430 |
Why?
|
| CA3 Region, Hippocampal | 1 | 2013 | 54 | 0.420 |
Why?
|
| Feedback, Physiological | 3 | 2021 | 476 | 0.420 |
Why?
|
| Protein Transport | 8 | 2020 | 1964 | 0.420 |
Why?
|
| Ubiquitin-Activating Enzymes | 1 | 2013 | 88 | 0.420 |
Why?
|
| Electron Transport Complex I | 1 | 2013 | 152 | 0.410 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 1 | 2013 | 159 | 0.410 |
Why?
|
| Microtubules | 2 | 2019 | 1072 | 0.410 |
Why?
|
| Coiled Bodies | 2 | 2003 | 5 | 0.410 |
Why?
|
| Nuclear Proteins | 11 | 2015 | 5791 | 0.400 |
Why?
|
| Vesicular Transport Proteins | 5 | 2020 | 374 | 0.400 |
Why?
|
| Cyclin D1 | 4 | 2002 | 451 | 0.390 |
Why?
|
| Leukemia, Myelomonocytic, Chronic | 1 | 2012 | 92 | 0.390 |
Why?
|
| Disease | 1 | 2017 | 671 | 0.390 |
Why?
|
| Iron | 3 | 2019 | 1786 | 0.380 |
Why?
|
| S Phase | 5 | 2013 | 422 | 0.380 |
Why?
|
| Cilia | 1 | 2015 | 493 | 0.380 |
Why?
|
| Amino Acid Sequence | 25 | 2017 | 13451 | 0.370 |
Why?
|
| Animals | 64 | 2021 | 167963 | 0.350 |
Why?
|
| Ubiquitin Thiolesterase | 2 | 2013 | 454 | 0.350 |
Why?
|
| Saccharomyces cerevisiae | 15 | 2020 | 2698 | 0.340 |
Why?
|
| Histones | 5 | 2017 | 2583 | 0.330 |
Why?
|
| Drosophila Proteins | 6 | 2013 | 1699 | 0.320 |
Why?
|
| Genes, Tumor Suppressor | 2 | 2012 | 1055 | 0.320 |
Why?
|
| Humans | 109 | 2022 | 760621 | 0.310 |
Why?
|
| Molecular Sequence Data | 23 | 2014 | 17624 | 0.310 |
Why?
|
| DNA Damage | 6 | 2015 | 2442 | 0.300 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2012 | 2828 | 0.300 |
Why?
|
| Calmodulin-Binding Proteins | 2 | 2020 | 232 | 0.290 |
Why?
|
| Mitosis | 5 | 2019 | 1191 | 0.270 |
Why?
|
| Endosomes | 3 | 2020 | 519 | 0.270 |
Why?
|
| Proteins | 9 | 2015 | 6029 | 0.260 |
Why?
|
| Cytosol | 2 | 2019 | 887 | 0.260 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2017 | 4357 | 0.260 |
Why?
|
| Host-Pathogen Interactions | 3 | 2021 | 1447 | 0.260 |
Why?
|
| Chromosome Segregation | 2 | 2017 | 233 | 0.260 |
Why?
|
| Homeostasis | 5 | 2020 | 3306 | 0.250 |
Why?
|
| Amygdala | 1 | 2013 | 1351 | 0.240 |
Why?
|
| Models, Molecular | 14 | 2017 | 5434 | 0.240 |
Why?
|
| Transcription Factors | 11 | 2020 | 12103 | 0.230 |
Why?
|
| TOR Serine-Threonine Kinases | 4 | 2017 | 2058 | 0.230 |
Why?
|
| RNA Interference | 8 | 2019 | 2846 | 0.230 |
Why?
|
| Cyclin-Dependent Kinase 2 | 7 | 2003 | 183 | 0.230 |
Why?
|
| Molecular Chaperones | 2 | 2000 | 752 | 0.220 |
Why?
|
| Phagosomes | 2 | 2015 | 199 | 0.220 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 7 | 2019 | 2873 | 0.220 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2013 | 2282 | 0.220 |
Why?
|
| Membrane Transport Proteins | 3 | 2019 | 1035 | 0.220 |
Why?
|
| DNA Replication | 3 | 2019 | 1412 | 0.210 |
Why?
|
| DNA-Binding Proteins | 7 | 2014 | 9585 | 0.210 |
Why?
|
| S-Phase Kinase-Associated Proteins | 9 | 2002 | 90 | 0.210 |
Why?
|
| Fungal Proteins | 6 | 2002 | 911 | 0.210 |
Why?
|
| Kinetics | 3 | 2020 | 6377 | 0.200 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2012 | 1394 | 0.200 |
Why?
|
| Meiosis | 2 | 2016 | 328 | 0.200 |
Why?
|
| Substrate Specificity | 8 | 2016 | 1792 | 0.200 |
Why?
|
| Drosophila | 2 | 2015 | 1492 | 0.190 |
Why?
|
| Cytoskeletal Proteins | 2 | 2015 | 1343 | 0.190 |
Why?
|
| Morphogenesis | 3 | 2015 | 740 | 0.190 |
Why?
|
| Colitis, Ulcerative | 1 | 2013 | 1919 | 0.190 |
Why?
|
| Papillomaviridae | 3 | 2012 | 1117 | 0.190 |
Why?
|
| Plant Growth Regulators | 1 | 2021 | 50 | 0.190 |
Why?
|
| Biological Assay | 2 | 2016 | 630 | 0.190 |
Why?
|
| Peptide Hydrolases | 2 | 2014 | 623 | 0.180 |
Why?
|
| Virus Replication | 3 | 2019 | 2432 | 0.180 |
Why?
|
| Mass Spectrometry | 6 | 2017 | 2192 | 0.180 |
Why?
|
| Mice | 35 | 2020 | 81208 | 0.180 |
Why?
|
| Cyclin G1 | 2 | 2017 | 15 | 0.180 |
Why?
|
| Crohn Disease | 1 | 2013 | 2275 | 0.180 |
Why?
|
| DiGeorge Syndrome | 1 | 2022 | 185 | 0.180 |
Why?
|
| DNA Repair | 4 | 2017 | 2039 | 0.180 |
Why?
|
| Hair Cells, Auditory | 1 | 2003 | 379 | 0.180 |
Why?
|
| Parkinson Disease | 4 | 2020 | 2859 | 0.180 |
Why?
|
| Chaperonins | 2 | 2016 | 58 | 0.170 |
Why?
|
| vif Gene Products, Human Immunodeficiency Virus | 1 | 2019 | 53 | 0.170 |
Why?
|
| Protein Structure, Tertiary | 7 | 2013 | 3800 | 0.170 |
Why?
|
| Hexokinase | 1 | 2019 | 125 | 0.170 |
Why?
|
| Oxidative Phosphorylation | 2 | 2019 | 495 | 0.160 |
Why?
|
| Glycerides | 1 | 2019 | 67 | 0.160 |
Why?
|
| Transcription Factor TFIIIA | 2 | 2015 | 24 | 0.160 |
Why?
|
| Cell Enlargement | 1 | 2019 | 60 | 0.160 |
Why?
|
| Deafness | 1 | 2003 | 457 | 0.160 |
Why?
|
| Genes, myc | 1 | 2000 | 395 | 0.160 |
Why?
|
| Dyneins | 1 | 2019 | 124 | 0.160 |
Why?
|
| Sphingolipids | 1 | 2020 | 173 | 0.160 |
Why?
|
| Angelman Syndrome | 2 | 2018 | 140 | 0.160 |
Why?
|
| GTP-Binding Proteins | 2 | 2003 | 951 | 0.160 |
Why?
|
| Enzyme Activation | 3 | 2018 | 3602 | 0.160 |
Why?
|
| Palmitic Acid | 1 | 2019 | 149 | 0.150 |
Why?
|
| Voltage-Dependent Anion Channel 1 | 1 | 2018 | 35 | 0.150 |
Why?
|
| I-kappa B Proteins | 1 | 1999 | 212 | 0.150 |
Why?
|
| Cell Division | 4 | 2019 | 4463 | 0.150 |
Why?
|
| Dosage Compensation, Genetic | 1 | 2019 | 207 | 0.150 |
Why?
|
| rab5 GTP-Binding Proteins | 1 | 2018 | 48 | 0.150 |
Why?
|
| Sequence Homology, Amino Acid | 7 | 2014 | 2753 | 0.150 |
Why?
|
| Wetlands | 1 | 2017 | 12 | 0.150 |
Why?
|
| Fas-Associated Death Domain Protein | 1 | 2017 | 27 | 0.150 |
Why?
|
| Caenorhabditis elegans Proteins | 2 | 2016 | 866 | 0.150 |
Why?
|
| Nerve Tissue Proteins | 3 | 2016 | 4407 | 0.140 |
Why?
|
| Bystander Effect | 1 | 2017 | 90 | 0.140 |
Why?
|
| TNF Receptor-Associated Factor 2 | 1 | 2017 | 57 | 0.140 |
Why?
|
| Microscopy, Fluorescence | 4 | 2015 | 2651 | 0.140 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2020 | 563 | 0.140 |
Why?
|
| Genes, Recessive | 1 | 2020 | 626 | 0.140 |
Why?
|
| COS Cells | 1 | 2019 | 1129 | 0.140 |
Why?
|
| Seawater | 1 | 2017 | 120 | 0.140 |
Why?
|
| Vacuoles | 1 | 2017 | 229 | 0.140 |
Why?
|
| Zebrafish | 2 | 2021 | 2997 | 0.140 |
Why?
|
| Ribosomal Proteins | 1 | 2019 | 363 | 0.140 |
Why?
|
| Cytoplasm | 2 | 2019 | 1516 | 0.140 |
Why?
|
| Fibroblasts | 7 | 2020 | 4090 | 0.140 |
Why?
|
| Purines | 1 | 2020 | 605 | 0.140 |
Why?
|
| Ribonuclease P | 1 | 2016 | 17 | 0.140 |
Why?
|
| Caspase 8 | 1 | 2017 | 189 | 0.140 |
Why?
|
| Ornithine Carbamoyltransferase | 1 | 2016 | 27 | 0.140 |
Why?
|
| Mitochondrial Encephalomyopathies | 1 | 2016 | 40 | 0.140 |
Why?
|
| alpha Catenin | 1 | 2016 | 37 | 0.140 |
Why?
|
| Centrioles | 1 | 2016 | 79 | 0.140 |
Why?
|
| Cell Line, Tumor | 7 | 2019 | 16939 | 0.140 |
Why?
|
| Antibodies, Monoclonal | 1 | 2013 | 9185 | 0.130 |
Why?
|
| Retinoblastoma Protein | 2 | 1997 | 670 | 0.130 |
Why?
|
| Dual-Specificity Phosphatases | 1 | 2016 | 71 | 0.130 |
Why?
|
| Sirtuin 3 | 1 | 2016 | 68 | 0.130 |
Why?
|
| S-Adenosylmethionine | 1 | 2017 | 213 | 0.130 |
Why?
|
| Intracellular Space | 1 | 2017 | 197 | 0.130 |
Why?
|
| Synaptonemal Complex | 1 | 2016 | 24 | 0.130 |
Why?
|
| Open Reading Frames | 2 | 2017 | 814 | 0.130 |
Why?
|
| Prostate | 1 | 2004 | 1793 | 0.130 |
Why?
|
| Crossing Over, Genetic | 1 | 2016 | 95 | 0.130 |
Why?
|
| Enzyme Inhibitors | 5 | 2017 | 3726 | 0.130 |
Why?
|
| Cell Physiological Phenomena | 1 | 2017 | 150 | 0.130 |
Why?
|
| Adherens Junctions | 1 | 2016 | 89 | 0.130 |
Why?
|
| Glycine | 1 | 2019 | 662 | 0.130 |
Why?
|
| Protein Stability | 2 | 2019 | 566 | 0.130 |
Why?
|
| Phenylketonurias | 1 | 2017 | 123 | 0.130 |
Why?
|
| Immune Evasion | 1 | 2019 | 362 | 0.130 |
Why?
|
| LLC-PK1 Cells | 1 | 2015 | 125 | 0.130 |
Why?
|
| Phosphatidylinositol Phosphates | 1 | 2016 | 202 | 0.130 |
Why?
|
| Jurkat Cells | 1 | 2017 | 736 | 0.130 |
Why?
|
| Aneuploidy | 1 | 2019 | 551 | 0.130 |
Why?
|
| DNA Helicases | 2 | 2012 | 854 | 0.130 |
Why?
|
| Immunoblotting | 2 | 2016 | 1649 | 0.130 |
Why?
|
| Lysine | 2 | 2017 | 1001 | 0.130 |
Why?
|
| Repressor Proteins | 3 | 2017 | 2981 | 0.120 |
Why?
|
| Cyclin C | 1 | 2014 | 12 | 0.120 |
Why?
|
| Cell Nucleus | 3 | 2019 | 2907 | 0.120 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2019 | 854 | 0.120 |
Why?
|
| beta Catenin | 2 | 2016 | 1043 | 0.120 |
Why?
|
| Cyclin-Dependent Kinase 4 | 4 | 2002 | 556 | 0.120 |
Why?
|
| Molecular Sequence Annotation | 1 | 2017 | 524 | 0.120 |
Why?
|
| Cytokinesis | 1 | 2016 | 172 | 0.120 |
Why?
|
| Cell Respiration | 1 | 2015 | 202 | 0.120 |
Why?
|
| Models, Biological | 5 | 2015 | 9467 | 0.120 |
Why?
|
| Endopeptidases | 2 | 2017 | 772 | 0.120 |
Why?
|
| Muscle Cells | 1 | 2015 | 195 | 0.120 |
Why?
|
| Cell Nucleolus | 1 | 2014 | 156 | 0.120 |
Why?
|
| Microfilament Proteins | 3 | 2016 | 1135 | 0.120 |
Why?
|
| Zinc | 1 | 2018 | 689 | 0.120 |
Why?
|
| Protein Interaction Domains and Motifs | 2 | 2013 | 453 | 0.120 |
Why?
|
| Glutamine | 1 | 2017 | 576 | 0.120 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 4 | 2003 | 319 | 0.120 |
Why?
|
| Amino Acids | 1 | 2020 | 1714 | 0.120 |
Why?
|
| Mutation | 14 | 2020 | 29932 | 0.110 |
Why?
|
| DNA, Ribosomal | 1 | 2014 | 285 | 0.110 |
Why?
|
| Mammals | 1 | 2019 | 1131 | 0.110 |
Why?
|
| Markov Chains | 1 | 2017 | 968 | 0.110 |
Why?
|
| Substantia Nigra | 1 | 2015 | 350 | 0.110 |
Why?
|
| Cell Differentiation | 7 | 2017 | 11481 | 0.110 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor Proteins | 4 | 2002 | 53 | 0.110 |
Why?
|
| Dystonia | 1 | 2017 | 364 | 0.110 |
Why?
|
| Cells, Cultured | 8 | 2019 | 18957 | 0.110 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 1996 | 423 | 0.110 |
Why?
|
| Oxidoreductases | 1 | 2015 | 412 | 0.110 |
Why?
|
| Serine | 1 | 2017 | 830 | 0.110 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2015 | 428 | 0.110 |
Why?
|
| Ecosystem | 1 | 2017 | 485 | 0.110 |
Why?
|
| Point Mutation | 1 | 2018 | 1594 | 0.110 |
Why?
|
| Amino Acid Motifs | 4 | 2003 | 929 | 0.110 |
Why?
|
| SNARE Proteins | 1 | 2013 | 80 | 0.110 |
Why?
|
| Binding Sites | 8 | 2017 | 6048 | 0.110 |
Why?
|
| Apoptosis | 6 | 2019 | 9501 | 0.110 |
Why?
|
| Sequence Alignment | 7 | 2020 | 2176 | 0.110 |
Why?
|
| Protein Multimerization | 2 | 2016 | 983 | 0.110 |
Why?
|
| Gene Dosage | 2 | 2016 | 1218 | 0.110 |
Why?
|
| Genes, X-Linked | 1 | 2013 | 128 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2019 | 1407 | 0.100 |
Why?
|
| Mitogen-Activated Protein Kinase 6 | 1 | 2012 | 11 | 0.100 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2017 | 789 | 0.100 |
Why?
|
| Microscopy, Confocal | 2 | 2016 | 1972 | 0.100 |
Why?
|
| Genetic Association Studies | 2 | 2020 | 2717 | 0.100 |
Why?
|
| Genes, Lethal | 1 | 2013 | 225 | 0.100 |
Why?
|
| Microcephaly | 1 | 2016 | 425 | 0.100 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2017 | 1135 | 0.100 |
Why?
|
| Protein Folding | 1 | 2016 | 867 | 0.100 |
Why?
|
| Arginine | 1 | 2016 | 934 | 0.100 |
Why?
|
| Acetylation | 4 | 2017 | 1062 | 0.100 |
Why?
|
| Tyrosine 3-Monooxygenase | 3 | 2020 | 370 | 0.100 |
Why?
|
| Down-Regulation | 2 | 2016 | 2913 | 0.100 |
Why?
|
| NF-kappa B | 2 | 2017 | 2488 | 0.100 |
Why?
|
| Immediate-Early Proteins | 1 | 2014 | 449 | 0.100 |
Why?
|
| Cell Death | 1 | 2017 | 1672 | 0.100 |
Why?
|
| Receptor, Notch1 | 1 | 2014 | 495 | 0.100 |
Why?
|
| Small Molecule Libraries | 1 | 2017 | 734 | 0.100 |
Why?
|
| Sirtuin 1 | 1 | 2013 | 247 | 0.100 |
Why?
|
| Mitochondrial Diseases | 1 | 2015 | 340 | 0.100 |
Why?
|
| Trans-Activators | 2 | 2013 | 2860 | 0.090 |
Why?
|
| Deoxyribonucleases | 1 | 2012 | 212 | 0.090 |
Why?
|
| Dendritic Spines | 1 | 2013 | 243 | 0.090 |
Why?
|
| Climate Change | 1 | 2017 | 488 | 0.090 |
Why?
|
| Environmental Monitoring | 1 | 2017 | 1441 | 0.090 |
Why?
|
| Heme Oxygenase-1 | 1 | 2013 | 364 | 0.090 |
Why?
|
| Obesity | 1 | 2013 | 12922 | 0.090 |
Why?
|
| Mixed Function Oxygenases | 1 | 2012 | 265 | 0.090 |
Why?
|
| Transcription, Genetic | 5 | 2014 | 7593 | 0.090 |
Why?
|
| Oncogene Proteins, Viral | 1 | 2012 | 341 | 0.090 |
Why?
|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2014 | 381 | 0.090 |
Why?
|
| Histone Demethylases | 1 | 2013 | 323 | 0.090 |
Why?
|
| Transfection | 3 | 2013 | 5781 | 0.090 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2013 | 376 | 0.090 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2015 | 633 | 0.090 |
Why?
|
| Caenorhabditis elegans | 3 | 2017 | 1444 | 0.090 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2022 | 1846 | 0.090 |
Why?
|
| Locomotion | 1 | 2013 | 387 | 0.090 |
Why?
|
| Lipid Metabolism | 1 | 2019 | 1902 | 0.090 |
Why?
|
| Crystallography, X-Ray | 6 | 2014 | 1982 | 0.090 |
Why?
|
| Mice, Inbred C57BL | 9 | 2019 | 22023 | 0.090 |
Why?
|
| DNA, Mitochondrial | 1 | 2015 | 858 | 0.090 |
Why?
|
| Chromosome Aberrations | 1 | 2016 | 1764 | 0.090 |
Why?
|
| Terminology as Topic | 1 | 2017 | 1535 | 0.090 |
Why?
|
| Sulfonamides | 1 | 2019 | 1977 | 0.080 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2014 | 730 | 0.080 |
Why?
|
| Immunoprecipitation | 3 | 2016 | 877 | 0.080 |
Why?
|
| Base Sequence | 7 | 2003 | 12446 | 0.080 |
Why?
|
| Anemia | 1 | 2019 | 1511 | 0.080 |
Why?
|
| Drosophila melanogaster | 3 | 2017 | 1710 | 0.080 |
Why?
|
| Single-Cell Analysis | 1 | 2020 | 2380 | 0.080 |
Why?
|
| Herpesvirus 1, Human | 1 | 2014 | 753 | 0.080 |
Why?
|
| Thalidomide | 1 | 2014 | 884 | 0.080 |
Why?
|
| Retinoblastoma-Binding Protein 1 | 2 | 1999 | 138 | 0.080 |
Why?
|
| Transcription Factor DP1 | 2 | 1999 | 136 | 0.080 |
Why?
|
| MAP Kinase Signaling System | 1 | 2016 | 1484 | 0.080 |
Why?
|
| Cyclin G | 2 | 1998 | 7 | 0.080 |
Why?
|
| Cloning, Molecular | 4 | 2000 | 4169 | 0.080 |
Why?
|
| Genomic Instability | 1 | 2012 | 704 | 0.080 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2019 | 1628 | 0.080 |
Why?
|
| Embryonic Development | 1 | 2013 | 716 | 0.080 |
Why?
|
| E2F Transcription Factors | 2 | 1999 | 269 | 0.080 |
Why?
|
| Structure-Activity Relationship | 4 | 2017 | 3084 | 0.070 |
Why?
|
| Liver Diseases | 1 | 2016 | 1302 | 0.070 |
Why?
|
| Neoplasm Proteins | 1 | 2019 | 3610 | 0.070 |
Why?
|
| Amyotrophic Lateral Sclerosis | 2 | 2015 | 1463 | 0.070 |
Why?
|
| Homeodomain Proteins | 2 | 2014 | 2414 | 0.070 |
Why?
|
| K562 Cells | 2 | 2019 | 640 | 0.070 |
Why?
|
| Cell Survival | 1 | 2017 | 5797 | 0.070 |
Why?
|
| Energy Metabolism | 2 | 2019 | 2869 | 0.070 |
Why?
|
| Oxygen Consumption | 1 | 2013 | 1843 | 0.070 |
Why?
|
| Mice, Knockout | 5 | 2019 | 14372 | 0.070 |
Why?
|
| Social Behavior | 1 | 2013 | 1131 | 0.070 |
Why?
|
| Blotting, Western | 3 | 2016 | 5039 | 0.070 |
Why?
|
| Hep G2 Cells | 2 | 2019 | 389 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2020 | 17790 | 0.060 |
Why?
|
| Memory Disorders | 1 | 2013 | 1197 | 0.060 |
Why?
|
| RNA, Small Interfering | 4 | 2019 | 3442 | 0.060 |
Why?
|
| Swine | 1 | 2015 | 5899 | 0.060 |
Why?
|
| Gene Expression Regulation | 4 | 2015 | 11903 | 0.060 |
Why?
|
| Mutation, Missense | 1 | 2014 | 2566 | 0.060 |
Why?
|
| Recombinant Proteins | 4 | 2002 | 6538 | 0.060 |
Why?
|
| Phenotype | 4 | 2020 | 16546 | 0.060 |
Why?
|
| G2 Phase | 2 | 2003 | 133 | 0.060 |
Why?
|
| Cell Movement | 2 | 2016 | 5206 | 0.060 |
Why?
|
| Cryoelectron Microscopy | 2 | 2020 | 642 | 0.060 |
Why?
|
| Methylation | 2 | 2017 | 1082 | 0.060 |
Why?
|
| Mammary Glands, Animal | 2 | 2017 | 271 | 0.060 |
Why?
|
| Genome, Human | 1 | 2017 | 4417 | 0.060 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 5 | 1999 | 358 | 0.060 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p19 | 1 | 2003 | 12 | 0.060 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2015 | 2471 | 0.060 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2019 | 1173 | 0.060 |
Why?
|
| Schizophrenia | 1 | 2022 | 6915 | 0.050 |
Why?
|
| Phylogeny | 2 | 2002 | 2775 | 0.050 |
Why?
|
| RNA, Messenger | 3 | 2016 | 12766 | 0.050 |
Why?
|
| Yeasts | 2 | 2002 | 279 | 0.050 |
Why?
|
| Genes, cdc | 1 | 2003 | 115 | 0.050 |
Why?
|
| Catalytic Domain | 2 | 2016 | 706 | 0.050 |
Why?
|
| Male | 16 | 2020 | 359744 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2017 | 2448 | 0.050 |
Why?
|
| CDC28 Protein Kinase, S cerevisiae | 1 | 2002 | 22 | 0.050 |
Why?
|
| Cyclin A | 1 | 2002 | 60 | 0.050 |
Why?
|
| Retinoblastoma-Like Protein p107 | 1 | 2002 | 71 | 0.050 |
Why?
|
| Female | 19 | 2020 | 391270 | 0.050 |
Why?
|
| Oxidative Stress | 1 | 2013 | 3106 | 0.050 |
Why?
|
| Tyrosine | 2 | 2017 | 1438 | 0.050 |
Why?
|
| Body Weight | 1 | 2013 | 4611 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 1 | 2013 | 5785 | 0.050 |
Why?
|
| Peptide Mapping | 1 | 2002 | 262 | 0.050 |
Why?
|
| Rabbits | 2 | 1999 | 4773 | 0.050 |
Why?
|
| Eukaryotic Cells | 1 | 2003 | 196 | 0.050 |
Why?
|
| Myogenin | 2 | 1999 | 55 | 0.050 |
Why?
|
| Mice, Transgenic | 4 | 2015 | 9530 | 0.050 |
Why?
|
| Prostatic Neoplasms | 1 | 2004 | 11345 | 0.050 |
Why?
|
| Luciferases | 1 | 2003 | 716 | 0.050 |
Why?
|
| Trypsin | 1 | 2002 | 496 | 0.050 |
Why?
|
| RNA-Binding Proteins | 3 | 2018 | 1894 | 0.050 |
Why?
|
| DNA Breaks, Double-Stranded | 2 | 2017 | 607 | 0.050 |
Why?
|
| Mice, Neurologic Mutants | 1 | 2020 | 107 | 0.040 |
Why?
|
| Schizosaccharomyces | 1 | 2002 | 237 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 2 | 2016 | 1617 | 0.040 |
Why?
|
| Zinc Fingers | 1 | 2002 | 568 | 0.040 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2019 | 3584 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2003 | 698 | 0.040 |
Why?
|
| Conserved Sequence | 2 | 2002 | 1167 | 0.040 |
Why?
|
| BRCA1 Protein | 2 | 2019 | 1147 | 0.040 |
Why?
|
| Myristic Acid | 1 | 2019 | 49 | 0.040 |
Why?
|
| RNA | 2 | 2022 | 2722 | 0.040 |
Why?
|
| Precipitin Tests | 1 | 2000 | 814 | 0.040 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2003 | 1693 | 0.040 |
Why?
|
| Brain | 3 | 2016 | 26951 | 0.040 |
Why?
|
| Molecular Structure | 3 | 2017 | 1895 | 0.040 |
Why?
|
| Motor Neuron Disease | 1 | 2020 | 98 | 0.040 |
Why?
|
| Protein Unfolding | 1 | 2019 | 56 | 0.040 |
Why?
|
| Macromolecular Substances | 2 | 2002 | 1433 | 0.040 |
Why?
|
| Pancreatic Neoplasms | 1 | 2017 | 5351 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2000 | 373 | 0.040 |
Why?
|
| Fatty Acids, Monounsaturated | 1 | 2020 | 190 | 0.040 |
Why?
|
| beta-Transducin Repeat-Containing Proteins | 1 | 1999 | 32 | 0.040 |
Why?
|
| E2F1 Transcription Factor | 1 | 1999 | 178 | 0.040 |
Why?
|
| Prognosis | 2 | 2013 | 29658 | 0.040 |
Why?
|
| Embryonic and Fetal Development | 1 | 1999 | 420 | 0.040 |
Why?
|
| Two-Hybrid System Techniques | 1 | 1999 | 458 | 0.040 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 1 | 2019 | 135 | 0.040 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2019 | 11712 | 0.040 |
Why?
|
| Golgi Apparatus | 1 | 2020 | 404 | 0.040 |
Why?
|
| Saccharomycetales | 1 | 2019 | 74 | 0.040 |
Why?
|
| Gene Knock-In Techniques | 1 | 2020 | 419 | 0.040 |
Why?
|
| Neoplasm Transplantation | 1 | 2002 | 2014 | 0.040 |
Why?
|
| Tacrolimus Binding Proteins | 1 | 2019 | 193 | 0.040 |
Why?
|
| Rats | 4 | 2013 | 23711 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2000 | 635 | 0.040 |
Why?
|
| Rad51 Recombinase | 1 | 2019 | 188 | 0.040 |
Why?
|
| Nervous System Malformations | 1 | 2020 | 244 | 0.040 |
Why?
|
| Follow-Up Studies | 2 | 2013 | 39261 | 0.040 |
Why?
|
| Kinetochores | 1 | 1999 | 178 | 0.040 |
Why?
|
| Plasmids | 1 | 2003 | 2275 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p57 | 4 | 1999 | 43 | 0.040 |
Why?
|
| Genes, Fungal | 1 | 1999 | 439 | 0.040 |
Why?
|
| Louisiana | 1 | 2017 | 104 | 0.040 |
Why?
|
| Cell Proliferation | 3 | 2019 | 10446 | 0.040 |
Why?
|
| Mississippi | 1 | 2017 | 93 | 0.040 |
Why?
|
| Tamoxifen | 1 | 2002 | 963 | 0.040 |
Why?
|
| Alabama | 1 | 2017 | 104 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 2 | 2002 | 6131 | 0.040 |
Why?
|
| Cell Line, Transformed | 1 | 1999 | 869 | 0.040 |
Why?
|
| Glutaminase | 1 | 2017 | 33 | 0.040 |
Why?
|
| Coenzymes | 1 | 1997 | 102 | 0.040 |
Why?
|
| Metalloproteins | 1 | 1997 | 101 | 0.040 |
Why?
|
| Beckwith-Wiedemann Syndrome | 1 | 1997 | 44 | 0.040 |
Why?
|
| Phenylalanine Hydroxylase | 1 | 2017 | 28 | 0.040 |
Why?
|
| Protein Kinase Inhibitors | 1 | 1993 | 5643 | 0.040 |
Why?
|
| Acyltransferases | 1 | 2019 | 305 | 0.040 |
Why?
|
| Protein Conformation | 2 | 2002 | 3969 | 0.040 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 1999 | 459 | 0.040 |
Why?
|
| Cell Size | 1 | 2019 | 624 | 0.030 |
Why?
|
| Embryo, Mammalian | 3 | 2017 | 1674 | 0.030 |
Why?
|
| Hemolysis | 1 | 2019 | 423 | 0.030 |
Why?
|
| Tryptophan Hydroxylase | 1 | 2017 | 94 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2001 | 3735 | 0.030 |
Why?
|
| Mitochondrial Proton-Translocating ATPases | 1 | 2016 | 53 | 0.030 |
Why?
|
| Cyclin D | 1 | 1996 | 72 | 0.030 |
Why?
|
| Texas | 1 | 2017 | 401 | 0.030 |
Why?
|
| Telomere-Binding Proteins | 1 | 2017 | 119 | 0.030 |
Why?
|
| Information Services | 1 | 2017 | 235 | 0.030 |
Why?
|
| Florida | 1 | 2017 | 430 | 0.030 |
Why?
|
| Morpholines | 1 | 2019 | 583 | 0.030 |
Why?
|
| Sampling Studies | 1 | 2017 | 613 | 0.030 |
Why?
|
| Oncogene Proteins | 1 | 2000 | 719 | 0.030 |
Why?
|
| Enzyme Stability | 1 | 1996 | 220 | 0.030 |
Why?
|
| Candida albicans | 1 | 2019 | 374 | 0.030 |
Why?
|
| Biocatalysis | 1 | 2016 | 172 | 0.030 |
Why?
|
| Receptors, Steroid | 1 | 2016 | 154 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2013 | 12914 | 0.030 |
Why?
|
| Breast Neoplasms | 2 | 2002 | 21025 | 0.030 |
Why?
|
| Phosphoserine | 1 | 2016 | 203 | 0.030 |
Why?
|
| Peptide Fragments | 2 | 2012 | 5125 | 0.030 |
Why?
|
| DNA, Complementary | 1 | 1999 | 1991 | 0.030 |
Why?
|
| Phenylalanine | 1 | 2017 | 365 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase 3 | 1 | 2014 | 10 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2013 | 20080 | 0.030 |
Why?
|
| Protein Structure, Secondary | 2 | 2012 | 1229 | 0.030 |
Why?
|
| Disease Progression | 2 | 2019 | 13502 | 0.030 |
Why?
|
| Retinoblastoma | 1 | 1998 | 317 | 0.030 |
Why?
|
| CDC2 Protein Kinase | 1 | 2016 | 213 | 0.030 |
Why?
|
| Contractile Proteins | 1 | 2016 | 240 | 0.030 |
Why?
|
| Tumor Suppressor Protein p53 | 3 | 2012 | 2919 | 0.030 |
Why?
|
| Motor Neurons | 1 | 2020 | 865 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase 8 | 1 | 2014 | 48 | 0.030 |
Why?
|
| Gene Expression Regulation, Fungal | 1 | 1997 | 499 | 0.030 |
Why?
|
| Tryptophan | 1 | 2017 | 479 | 0.030 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2016 | 235 | 0.030 |
Why?
|
| Peptide Library | 1 | 2016 | 347 | 0.030 |
Why?
|
| Levodopa | 1 | 2015 | 217 | 0.030 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2017 | 397 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2016 | 478 | 0.030 |
Why?
|
| Disease-Free Survival | 1 | 2004 | 6828 | 0.030 |
Why?
|
| Transplantation, Heterologous | 1 | 2002 | 2379 | 0.030 |
Why?
|
| Molecular Weight | 1 | 1996 | 2186 | 0.030 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2002 | 1529 | 0.030 |
Why?
|
| Sumoylation | 1 | 2014 | 83 | 0.030 |
Why?
|
| Sirtuins | 1 | 2016 | 320 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2019 | 8515 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 2003 | 6068 | 0.030 |
Why?
|
| Muscle, Skeletal | 3 | 1999 | 4925 | 0.030 |
Why?
|
| Biological Availability | 1 | 2014 | 395 | 0.030 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2014 | 435 | 0.030 |
Why?
|
| Gene Knockout Techniques | 1 | 2016 | 802 | 0.030 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 1 | 2015 | 415 | 0.030 |
Why?
|
| Biosensing Techniques | 1 | 2019 | 677 | 0.030 |
Why?
|
| Antigens, Polyomavirus Transforming | 1 | 1993 | 257 | 0.030 |
Why?
|
| Structural Homology, Protein | 1 | 2012 | 86 | 0.030 |
Why?
|
| Hormones | 1 | 2017 | 867 | 0.030 |
Why?
|
| Time Factors | 2 | 2013 | 40165 | 0.030 |
Why?
|
| Pluripotent Stem Cells | 1 | 2020 | 792 | 0.030 |
Why?
|
| GTPase-Activating Proteins | 1 | 2016 | 475 | 0.030 |
Why?
|
| HIV Infections | 1 | 2019 | 17165 | 0.030 |
Why?
|
| Mutant Proteins | 1 | 2014 | 492 | 0.030 |
Why?
|
| Siblings | 1 | 2016 | 824 | 0.030 |
Why?
|
| Serotonin | 1 | 2017 | 1040 | 0.020 |
Why?
|
| Multienzyme Complexes | 1 | 2015 | 666 | 0.020 |
Why?
|
| Multigene Family | 1 | 1995 | 1077 | 0.020 |
Why?
|
| Steroids | 1 | 2017 | 928 | 0.020 |
Why?
|
| Viral Proteins | 1 | 1999 | 1802 | 0.020 |
Why?
|
| Cadherins | 1 | 2016 | 898 | 0.020 |
Why?
|
| Endodeoxyribonucleases | 1 | 2012 | 164 | 0.020 |
Why?
|
| Radiation Tolerance | 1 | 2013 | 480 | 0.020 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2012 | 400 | 0.020 |
Why?
|
| Cell Separation | 1 | 2017 | 1720 | 0.020 |
Why?
|
| NIH 3T3 Cells | 1 | 2012 | 670 | 0.020 |
Why?
|
| Genes | 1 | 2015 | 1845 | 0.020 |
Why?
|
| Dogs | 1 | 2016 | 3841 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2004 | 12159 | 0.020 |
Why?
|
| Neurodegenerative Diseases | 1 | 2020 | 1084 | 0.020 |
Why?
|
| Exons | 1 | 2017 | 2388 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2004 | 11071 | 0.020 |
Why?
|
| Aged, 80 and over | 3 | 2019 | 58995 | 0.020 |
Why?
|
| Retrospective Studies | 2 | 2013 | 80372 | 0.020 |
Why?
|
| Adult | 4 | 2019 | 219994 | 0.020 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2016 | 1949 | 0.020 |
Why?
|
| Organoids | 1 | 2016 | 729 | 0.020 |
Why?
|
| Protein Structure, Quaternary | 2 | 2002 | 428 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2015 | 2057 | 0.020 |
Why?
|
| Abnormalities, Multiple | 1 | 1997 | 1415 | 0.020 |
Why?
|
| Dopamine | 1 | 2017 | 1595 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2016 | 3094 | 0.020 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2017 | 1245 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2017 | 2668 | 0.020 |
Why?
|
| Pedigree | 1 | 2017 | 4578 | 0.020 |
Why?
|
| DNA | 3 | 2017 | 7233 | 0.020 |
Why?
|
| Actins | 1 | 2016 | 2049 | 0.020 |
Why?
|
| Gene Regulatory Networks | 1 | 2017 | 1741 | 0.020 |
Why?
|
| Gene Expression | 3 | 2014 | 7588 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2004 | 15289 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 1999 | 3604 | 0.020 |
Why?
|
| Neoplasms | 1 | 2016 | 22072 | 0.020 |
Why?
|
| Models, Theoretical | 1 | 2019 | 3562 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 4573 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 2014 | 1664 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2015 | 6238 | 0.020 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2019 | 4353 | 0.020 |
Why?
|
| Transforming Growth Factor beta | 1 | 2014 | 1959 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2017 | 5870 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2004 | 9276 | 0.020 |
Why?
|
| Lens, Crystalline | 2 | 1998 | 388 | 0.020 |
Why?
|
| Alleles | 1 | 2017 | 6898 | 0.020 |
Why?
|
| Antigens, CD | 1 | 2016 | 4000 | 0.020 |
Why?
|
| Computational Biology | 1 | 2017 | 3505 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2017 | 10827 | 0.020 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2019 | 5253 | 0.010 |
Why?
|
| Genome | 1 | 2012 | 1739 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2015 | 4713 | 0.010 |
Why?
|
| Epigenesis, Genetic | 1 | 2017 | 3758 | 0.010 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2017 | 4048 | 0.010 |
Why?
|
| Chromatin | 1 | 2015 | 2938 | 0.010 |
Why?
|
| Aged | 3 | 2019 | 169152 | 0.010 |
Why?
|
| Risk | 1 | 2015 | 9631 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 2014 | 3663 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2016 | 6218 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2004 | 41335 | 0.010 |
Why?
|
| Middle Aged | 3 | 2019 | 220352 | 0.010 |
Why?
|
| Research Design | 1 | 2017 | 6180 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2017 | 9411 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2020 | 18137 | 0.010 |
Why?
|
| RNA, Double-Stranded | 1 | 2001 | 295 | 0.010 |
Why?
|
| DNA Methylation | 1 | 2013 | 4373 | 0.010 |
Why?
|
| Suppression, Genetic | 1 | 1999 | 190 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2017 | 22053 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2017 | 12626 | 0.010 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 1 | 1999 | 307 | 0.010 |
Why?
|
| Kidney Medulla | 1 | 1997 | 169 | 0.010 |
Why?
|
| Adrenal Cortex | 1 | 1997 | 134 | 0.010 |
Why?
|
| Blastocyst | 1 | 1999 | 433 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2016 | 26181 | 0.010 |
Why?
|
| Pregnancy | 2 | 2013 | 29749 | 0.010 |
Why?
|
| Crosses, Genetic | 1 | 1997 | 751 | 0.010 |
Why?
|
| Hernia, Umbilical | 1 | 1997 | 102 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 1998 | 1763 | 0.010 |
Why?
|
| Bone Development | 1 | 1999 | 472 | 0.010 |
Why?
|
| Temperature | 1 | 2002 | 2221 | 0.010 |
Why?
|
| MyoD Protein | 1 | 1995 | 142 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 1995 | 410 | 0.010 |
Why?
|
| Gene Targeting | 1 | 1997 | 839 | 0.010 |
Why?
|
| Cartilage | 1 | 1997 | 806 | 0.010 |
Why?
|
| Karyotyping | 1 | 1995 | 1171 | 0.010 |
Why?
|
| Genes, p53 | 1 | 1995 | 713 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2019 | 65017 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 2017 | 13262 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 1997 | 2672 | 0.010 |
Why?
|
| Abdomen | 1 | 1997 | 1130 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 1995 | 1900 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 1995 | 2262 | 0.010 |
Why?
|
| Evolution, Molecular | 1 | 1999 | 1885 | 0.010 |
Why?
|
| Gestational Age | 1 | 1999 | 3565 | 0.010 |
Why?
|
| Osteogenesis | 1 | 1997 | 1271 | 0.010 |
Why?
|
| Neoplasms, Experimental | 1 | 1995 | 1229 | 0.010 |
Why?
|
| Placenta | 1 | 1998 | 1702 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 1995 | 2506 | 0.010 |
Why?
|
| Young Adult | 1 | 2015 | 58741 | 0.000 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1999 | 8158 | 0.000 |
Why?
|
| Chromosome Mapping | 1 | 1995 | 4625 | 0.000 |
Why?
|
| Adolescent | 1 | 2015 | 87810 | 0.000 |
Why?
|
| Liver | 1 | 1999 | 7509 | 0.000 |
Why?
|
| Lung | 1 | 1999 | 9994 | 0.000 |
Why?
|